| [1] |
Hesketh PJ, Kris MG, Basch E, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update[J]. J Clin Oncol, 2017, 35(28): 3240-3261. DOI: 10.1200/JCO.2017.74.4789.
doi: 10.1200/JCO.2017.74.4789
pmid: 28759346
|
| [2] |
国家卫生健康委员会医院管理研究所; 中华医学会肠外肠内营养学分会; 中华医学会肠外肠内营养学分会肠道微生态协作组. 肠道菌群移植临床应用管理中国专家共识(2022版)[J]. 中华胃肠外科杂志, 2022, 25(9): 747-756. DOI: 10.3760/cma.j.cn441530-20220725-00324.
doi: 10.3760/cma.j.cn441530-20220725-00324
|
| [3] |
中国抗癌协会肿瘤与微生态专业委员会. 肠道微生态与造血干细胞移植相关性中国专家共识[J]. 国际肿瘤学杂志, 2021, 48(3): 129-135. DOI: 10.3760/cma.j.cn371439-20210202-00027.
doi: 10.3760/cma.j.cn371439-20210202-00027
|
| [4] |
Gupta K, Walton R, Kataria SP. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends[J]. Cancer Treat Res Commun, 2021, 26: 100278. DOI: 10.1016/j.ctarc.2020.100278.
doi: 10.1016/j.ctarc.2020.100278
|
| [5] |
Razvi Y, Chan S, McFarlane T, et al. ASCO, NCCN, MASCC/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients[J]. Support Care Cancer, 2019, 27(1): 87-95. DOI: 10.1007/s00520-018-4464-y.
doi: 10.1007/s00520-018-4464-y
pmid: 30284039
|
| [6] |
Hong CHL, Gueiros LA, Fulton JS, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines[J]. Support Care Cancer, 2019, 27(10): 3949-3967. DOI: 10.1007/s00520-019-04848-4.
doi: 10.1007/s00520-019-04848-4
pmid: 31286232
|
| [7] |
Bowen JM, Wardill HR. Advances in the understanding and manage-ment of mucositis during stem cell transplantation[J]. Curr Opin Support Palliat Care, 2017, 11(4): 341-346. DOI: 10.1097/SPC.0000000000000310.
doi: 10.1097/SPC.0000000000000310
|
| [8] |
Ando T, Sakumura M, Mihara H, et al. A review of potential role of capsule endoscopy in the work-up for chemotherapy-induced diarrhea[J]. Healthcare (Basel), 2022, 10(2): 218. DOI: 10.3390/healthcare10020218.
doi: 10.3390/healthcare10020218
|
| [9] |
Hay T, Bellomo R, Rechnitzer T, et al. Constipation, diarrhea, and prophylactic laxative bowel regimens in the critically ill: a systematic review and meta-analysis[J]. J Crit Care, 2019, 52: 242-250. DOI: 10.1016/j.jcrc.2019.01.004.
doi: S0883-9441(18)31259-0
pmid: 30665795
|
| [10] |
Agamennone V, Krul CAM, Rijkers G, et al. A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in the Netherlands[J]. BMC Gastroenterol, 2018, 18(1): 103. DOI: 10.1186/s12876-018-0831-x.
doi: 10.1186/s12876-018-0831-x
pmid: 30078376
|
| [11] |
Wang Y, Abu-Sbeih H, Mao E, et al. Immune-checkpoint inhi-bitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson[J]. J Immunother Cancer, 2018, 6(1): 37. DOI: 10.1186/s40425-018-0346-6.
doi: 10.1186/s40425-018-0346-6
|
| [12] |
Taplitz RA, Kennedy EB, Bow EJ, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and infectious diseases society of America clinical practice guideline update[J]. J Clin Oncol, 2018, 36(14): 1443-1453. DOI: 10.1200/JCO.2017.77.6211.
doi: 10.1200/JCO.2017.77.6211
pmid: 29461916
|
| [13] |
Cooksley T, Font C, Scotte F, et al. Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paper[J]. Support Care Cancer, 2021, 29(2): 1129-1138. DOI: 10.1007/s00520-020-05906-y.
doi: 10.1007/s00520-020-05906-y
pmid: 33230644
|
| [14] |
Kapandji N, Azoulay E, Zafrani L. Recent advances in neutropenic enterocolitis: insights into the role of gut microbiota[J]. Blood Rev, 2022, 54: 100944. DOI: 10.1016/j.blre.2022.100944.
doi: 10.1016/j.blre.2022.100944
|
| [15] |
Duceau B, Picard M, Pirracchio R, et al. Neutropenic enterocolitis in critically ill patients: spectrum of the disease and risk of invasive fungal disease[J]. Crit Care Med, 2019, 47(5): 668-676. DOI: 10.1097/CCM.0000000000003687.
doi: 10.1097/CCM.0000000000003687
pmid: 30741755
|
| [16] |
Benedetti E, Bruno B, Martini F, et al. Early diagnosis of neu-tropenic enterocolitis by bedside ultrasound in hematological malignancies: a prospective study[J]. J Clin Med, 2021, 10(18): 4277. DOI: 10.3390/jcm10184277.
doi: 10.3390/jcm10184277
|
| [17] |
Khanna S. Advances in clostridioides difficile therapeutics[J]. Expert Rev Anti Infect Ther, 2021, 19(9): 1067-1070. DOI: 10.1080/14787210.2021.1874919.
doi: 10.1080/14787210.2021.1874919
|
| [18] |
Quraishi MN, Widlak M, Bhala N, et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection[J]. Aliment Pharmacol Ther, 2017, 46(5): 479-493. DOI: 10.1111/apt.14201.
doi: 10.1111/apt.14201
|
| [19] |
Hou K, Wu ZX, Chen XY, et al. Microbiota in health and diseases[J]. Signal Transduct Target Ther, 2022, 7(1): 135. DOI: 10.1038/s41392-022-00974-4.
doi: 10.1038/s41392-022-00974-4
|
| [20] |
Martin A, Fahrbach K, Zhao Q, et al. Association between carba-penem resistance and mortality among adult, hospitalized patients with serious infections due to Enterobacteriaceae: results of a systematic literature review and meta-analysis[J]. Open Forum Infect Dis, 2018, 5(7): ofy150. DOI: 10.1093/ofid/ofy150.
doi: 10.1093/ofid/ofy150
|
| [21] |
Cammarota G, Ianiro G, Kelly CR, et al. International consensus conference on stool banking for faecal microbiota transplantation in clinical practice[J]. Gut, 2019, 68(12): 2111-2121. DOI: 10.1136/gutjnl-2019-319548.
doi: 10.1136/gutjnl-2019-319548
pmid: 31563878
|
| [22] |
Guo Z, Gao HY, Zhang TY, et al. Analysis of allogeneic hemato-poietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia[J]. Int J Hematol, 2016, 104(6): 720-728. DOI: 10.1007/s12185-016-2106-z.
doi: 10.1007/s12185-016-2106-z
|
